Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa

* Tadekinig alfa is a novel IL-18 binding protein in pivotal Phase 3 testing for orphan disease IL-18 driven monogenic Hemophagocytic Lymphohistiocytosis (HLH) * WuXi Biologics to undertake commercial-scale manufacturing to support U.S. market launch SHANGHAI and LAUSANNE, Switzerland, Oct. 2...

2020-10-29 17:00 2068

Human-Machine Competition: Ping An's AskBob Doctor's AI Matches Doctors' Capabilities in Cardiovascular Disease Management

HONG KONG and SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 02318; SSE: 601318) announced thatPing An's AskBob Doctor has demonstrated that its artificial intelligence (AI) capabilities in cardiovascular disease ...

2020-10-29 16:50 5142

Tencent Cloud Backs the 11th Ageing Asia 2020 - World Ageing Festival with its Innovative Cloud Conferencing Solutions

SINGAPORE, Oct. 29, 2020 /PRNewswire/ -- Tencent Cloud today announced its support for the11th Ageing Asia 2020 – World Ageing Festival (AA2020 – WAF) through its secure and stableTencent Cloud Conference (TCC) solutions, offering global audiences a seamless and high-quality online exhibition vie...

2020-10-29 11:40 1509

Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity

HONG KONG, Oct. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc, a company recently acquired by the Group which is a pioneer in deep biomarkers of agin...

2020-10-29 09:57 5045

Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia

SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, today announced that Australian regulatory authorities have approved it...

2020-10-29 09:35 1689

INC Consumer Study Finds Energy Boosting and Digestive Healthy Foods Among the Fastest Growing Trends, with Immune Support Expected to Grow

REUS, Spain, Oct. 29, 2020 /PRNewswire/ -- Consuming foods that boost energy, and support digestive health are among the largest and fastest growing consumer trends. In a recent consumer trend study, it was found that these two markets are forecasted to be the fastest growers among the health and...

2020-10-29 09:00 2534

Samsung Biologics expands global footprint with opening of new San Francisco CDO R&D Center

INCHEON, South Korea and SAN FRANCISCO, Oct. 28, 2020 /PRNewswire/ -- At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center inSan Francisco, bringing its contract development services closer to global clients. As the "Next Door ...

2020-10-29 08:38 6437

CStone and LegoChem Biosciences Enter Global Licensing Agreement for New Antibody Drug Conjugate

* CStone to acquire exclusive rights for development and commercialization outsideSouth Korea for LCB71, an ROR1 antibody drug conjugate * Agreement adds to CStone's pipeline a potential first-in-class/best-in-class drug candidate with monotherapy and combination applications for a range of c...

2020-10-29 07:15 3235

BioInvent Completes First Licensing Agreement in Greater China, Advised by MSQ Ventures

NEW YORK, Oct. 29, 2020 /PRNewswire/ -- M.S.Q. Ventures ("MSQ") announced today that its client, BioInvent International, AB ("BioInvent"), has successfully entered into a licensing agreement with CASI Pharmaceuticals, Inc. ("CASI") for the development and commercialization of BI-1206 in theGreat...

2020-10-29 02:51 2360

Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus

SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- Daewoong Pharmaceutical, a South Korean pharmaceutical giant announced that its Covid-19 treatment candidate of sustained-release niclosamide (DWRX2003) also showed promising study results for a fight against the upcoming 'Twindemic' involving COV...

2020-10-28 22:36 1378

Yuyu Pharma Announces the Introduction of Anti-Bribery Management System to meet Global Standards

SEOUL, South Korea, Oct. 28, 2020 /PRNewswire/ -- On October 28, 2020, Yuyu Pharm (CEO Robert Wonsang Yu, KRX 000220) initiated steps to incorporate ISO 37001 Anti-bribery management system to strengthen the company's compliance system. During the introduction ceremony of ISO 37001 held at Yuyu P...

2020-10-28 21:00 1572

Yuyu Pharma Announces the Introduction of Anti-Bribery Management System to meet Global Standards

Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies

SHANGHAI and SUZHOU, China, Oct. 28, 2020 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced it has secured$100 million i...

2020-10-28 21:00 1870

I-Mab Announces Upcoming Participation at November Conferences

SHANGHAI, China, and GAITHERSBURG, MD., Oct. 28, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced its participation in the following conferences i...

2020-10-28 20:00 2607

MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Wristed Surgical Instruments

First Procedures Performed with the Symani Surgical System CALCI, Italy, Oct. 28, 2020 /PRNewswire/ -- MMI SpA, an Italian company dedicated to improving clinical outcomes for patients undergoing microsurgery, announced today the CE Mark, launch and first human use of its Symani® Surgical Syste...

2020-10-28 20:00 2504

MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World's Smallest Wristed Surgical Instruments

Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019

SHIJIAZHUANG, China, Oct. 28, 2020 /PRNewswire/ -- On October 27, Yiling Pharmaceutical (002603.SZ) released its 2020 third quarter report. In the first three quarters of the year, Yiling Pharmaceutical achieved the total operating revenue of6.447 billion yuan (about US$962 million), a 48.31% yea...

2020-10-28 17:04 5989

The Rockefeller Foundation commits USD1 billion to catalyze a green recovery from pandemic

NEW YORK, Oct. 28, 2020 /PRNewswire/ -- The Rockefeller Foundation will commit USD1 billion over the next three years to catalyze a more inclusive, green recovery from theCOVID-19 pandemic. Building on current efforts and long-standing programs, the Foundation will focus on two key areas: catalyz...

2020-10-28 15:57 1571

Belle Cosmic Manufacturing Presents Portable UV Disinfecting Cases for the Cosmetic Packaging Industry

HONG KONG, Oct. 28, 2020 /PRNewswire/ -- The coronavirus pandemic has made hygiene a topmost priority, with many people opting to carry a bottle of hand sanitizer with them so that they can disinfect their hands anytime, anywhere. Belle Cosmic Manufacturing Co. Ltd.,Hong Kong, SAR China, has take...

2020-10-28 15:14 1457

Belle Cosmic Manufacturing Presents Portable UV Disinfecting Cases for the Cosmetic Packaging Industry

APRINOIA Announces Approval from NMPA to Initiate Phase 3 Clinical Trial in China for [18F]-APN-1607 Tau PET Imaging Tracer for Dementia

SUZHOU, China, Oct. 28, 2020 /PRNewswire/ -- APRINOIA Therapeutics announced today that China National Medical Products Administration (NMPA) had approved to initiate Phase 3 clinical trial to evaluate APRINOIA's positron emission tomography (PET) imaging tracer, [18F]-APN-1607, targeting abnorma...

2020-10-28 14:00 1946

China Matters Documents the Collective Nucleic Acid Testing in Beijing

BEIJING, Oct. 28, 2020 /PRNewswire/ -- Collective testing served as a critical approach inChina for emergency response in face of the coronavirus outbreak. In mid-October, a cluster of COVID-19 infections was found in Qingdao. The local government immediately organized a collective nucleic ac...

2020-10-28 08:04 1574

China Matters Documents the Collective Nucleic Acid Testing in Beijing

China Matters presents Documentary on 42,000 Portraits of COVID-19 Frontline Workers in Wuhan

BEIJING, Oct. 28, 2020 /PRNewswire/ -- Taking photos for some 42,000 medical workers fighting COVID-19 inWuhan is a phenomenal project that Li Ge never did before. With over 20 years' experience, the photojournalistic went to Wuhan with a photographers' team, capturing the portraits of medica...

2020-10-28 07:56 1856

China Matters presents Documentary on 42,000 Portraits of COVID-19 Frontline Workers in Wuhan

1 ... 609 610 611612613 614 615 ... 808